Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Leckie, M. J.
Right arrow Articles by Rees, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leckie, M. J.
Right arrow Articles by Rees, R. G.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2002; 41: 473-474
© 2002 British Society for Rheumatology

Letters to the Editor

Stevens–Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis

M. J. Leckie and R. G. Rees

Department of Rheumatology, St Mary's NHS Trust, St Mary's Hospital, Praed Street, London W2 1NY, UK

SIR, Hydroxychloroquine is widely used in the treatment of rheumatoid arthritis and systemic lupus erythematosus, with very few reported side-effects. We report the case of a 65-yr-old woman who developed Stevens–Johnson syndrome 2 weeks after commencing treatment with hydroxychloroquine. Our patient had a 9-yr history of rheumatoid arthritis with multiple episodes of relapse and remission. She . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?